Advanced search
Publication Cover
Cancer Investigation Volume 8, 1990 - Issue 3-4
Submit an article Journal homepage
5
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Platinol (CDDP) and Continuous Intravenous Infusion 5-Fluorouracil in Refractory Stage IV Breast Cancer: A Phase II Study

Jacob D. Bitran Department of Medicine Sections of Hematology, Oncology University of Chicago and Michael Reese Medical Centers, Chicago, Illinois
,
Mark F. Kozloff Department of Medicine Sections of Hematology, Oncology University of Chicago and Michael Reese Medical Centers, Chicago, Illinois
&
Richard K. Desser Department of Medicine Sections of Hematology, Oncology University of Chicago and Michael Reese Medical Centers, Chicago, Illinois
Pages 335-338 | Published online: 11 Jun 2009

References

  • Canellos G P, Pocock S J, Taylor S G. Combination chemotherapy for metastatic breast carcinoma; prospective comparison of multiple drug therapy with L-phenylalanine mustard. Cancer 1976; 38: 1881–1886
  • Smalley R V. Five clinical patterns of recurrence of carcinoma of the breast. Proc ASCO, AACR 1976; 17: 172
  • Swenerton K D, Legha S S, Smith T, et al. Prognostic factors in metastatic breast cancer treated with combination chemotherapy. Cancer Res 1979; 39: 1552–1562
  • Perloff M, Hart R D, Holland J F. Vinblastine, adriamycin, thiotepa and halotestin (VATH): Therapy for advanced breast cancer refractory to prior chemotherapy. Cancer 1978; 42: 2534–2537
  • Konits P H, Aisner J, Van Echo D A, et al. Mitomycin-C and vinblastine chemotherapy for advanced breast cancer. Cancer 1981; 48: 1295–1298
  • Yap H J, Salem P, Hortobagyi G N, et al. Phase II study of cis-dichlorodimmine platinum (II) in advanced breast cancer. Cancer Treat Rep 1978; 62: 405–508
  • Ostrow S, Egorin M, Aisner J, et al. High-dose cis-diamminedichloro platinum therapy in patients with advanced breast cancer: pharmacokinetics, toxicity, and therapeutic efficacy. Cancer Clin Trials 1980; 3: 23–27
  • Martino S, Samal B A, Singhakowinta A, et al. A phase II study of cis-diamminedichloroplatinum II for advanced breast cancer—two dose schedules. J Cancer Res Clin Oncol 1984; 108: 354–356
  • Kolaric K, Roth A. Phase II clinical trial of cis-dichlorodiammine platinum (cis-DDP) for antitumorigenic activity in previously untreated patients with metastatic breast cancer. Cancer Chemother Pharmacol 1984; 11: 108–112
  • Sledge G W, Loehrer P J, Roth B J, et al. Cisplatin as first-line therapy for metastatic breast cancer. J Clin Oncol 1988; 6: 1811–1814
  • Singhakowinta A, Samal B A, Vaitkevicius V K. Continuous intravenous low dose 5-fluorouracil as a third line chemotherapy for metastatic breast cancer. Breast Cancer Res Treat 1987; 10: 108
  • Hatfield A K, Johnson P A, Egner J R. Long term continuous 5-fluorouracil (5-FU) infusion in the treatment of far advanced breast carcinoma. Breast Cancer Res Treat 1987; 10: 109
  • Jacobs S A, Stoller R G, Earle M F. 96-hour 5-fluorouracil (5FU) infusion plus cis-platinum (DDP) in advanced breast cancer. Proc ASCO 1985; 4: 71
  • Gonzales F, Anton-Aparicio L, Dy C, et al. 120 hours simultaneous infusion of cisplatinum (CDDP) and fluorouracil (5-FU) in drug resistant metastatic breast cancer. Proc ASCO 1986; 5: 59
  • Pronzato P, Amoroso D, Bertilli G, et al. Salvage treatment with cisplatin (CDDP) and 5-fluorouracil (5-FU) in advanced breast cancer patients. Breast Cancer Res Treat 1987; 10: 108

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.